DE3473732D1 - Transdermal drug form - Google Patents

Transdermal drug form

Info

Publication number
DE3473732D1
DE3473732D1 DE8484400584T DE3473732T DE3473732D1 DE 3473732 D1 DE3473732 D1 DE 3473732D1 DE 8484400584 T DE8484400584 T DE 8484400584T DE 3473732 T DE3473732 T DE 3473732T DE 3473732 D1 DE3473732 D1 DE 3473732D1
Authority
DE
Germany
Prior art keywords
transdermal drug
drug form
reversible
crosslinked
hydrophobic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484400584T
Other languages
English (en)
Inventor
Johnny Haggiage
Christian Pusineri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Sante SA
Original Assignee
Rhone Poulenc Sante SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante SA filed Critical Rhone Poulenc Sante SA
Application granted granted Critical
Publication of DE3473732D1 publication Critical patent/DE3473732D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8484400584T 1983-03-24 1984-03-22 Transdermal drug form Expired DE3473732D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8304839A FR2542998B1 (fr) 1983-03-24 1983-03-24 Nouvelle forme transdermale du dinitrate d'isosorbide

Publications (1)

Publication Number Publication Date
DE3473732D1 true DE3473732D1 (en) 1988-10-06

Family

ID=9287188

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484400584T Expired DE3473732D1 (en) 1983-03-24 1984-03-22 Transdermal drug form

Country Status (7)

Country Link
US (1) US4746509A (de)
EP (1) EP0123585B1 (de)
JP (1) JPS59181207A (de)
AT (1) ATE36809T1 (de)
CA (1) CA1209476A (de)
DE (1) DE3473732D1 (de)
FR (1) FR2542998B1 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60174716A (ja) * 1984-02-21 1985-09-09 Yamanouchi Pharmaceut Co Ltd パツチ剤
JPS60224638A (ja) * 1984-04-23 1985-11-09 Kao Corp 経皮吸収促進剤およびこれを含有する外用剤
US4638043A (en) * 1984-11-13 1987-01-20 Thermedics, Inc. Drug release system
FR2612785A1 (fr) * 1987-03-25 1988-09-30 Lhd Lab Hygiene Dietetique Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee
US4898920A (en) * 1987-10-15 1990-02-06 Dow Corning Corporation Adhesive compositions, controlled release compositions and transdermal delivery device
US4906475A (en) 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US4837025A (en) * 1988-03-25 1989-06-06 Laboratoires D'hygiene Et De Dietetique Self-adhesive device for the percutaneous administration of an active ingredient
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
US5053227A (en) * 1989-03-22 1991-10-01 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
DK0431519T3 (da) * 1989-12-04 1994-07-04 Searle & Co System til transdermal indgivelse af albuterol
US6559186B1 (en) * 1990-02-26 2003-05-06 Arc 1, Inc. Compositions and methods of treatment of sympathetically maintained pain
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
US5227169A (en) * 1991-05-17 1993-07-13 Theratech, Inc. Sorbitan esters as skin permeation enhancers
CA2099273C (en) * 1991-11-02 2000-03-28 Yasuo Shikinami Pressure sensitive adhesives for transdermal absorption formulations
US5543407A (en) * 1992-09-30 1996-08-06 Ningbo Institute Of Microcirculation And Henbane Preparation and application of scopolamine and chlorpromazine as a drug-withdrawal agent
EP0746301A1 (de) * 1992-11-23 1996-12-11 Estee Lauder Inc. Selbstbräunende kosmetische mittel und verfahren für ihre verwendung
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
US5773490A (en) * 1993-06-24 1998-06-30 Takiron Co., Ltd. Pressure sensitive adhesive for transdermal absorption formulations
US5411734A (en) * 1993-11-15 1995-05-02 Elizabeth Arden Company, Division Of Conopco, Inc. Non-irritating α-hydroxy carboxylic acid compositions
US5665378A (en) * 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
US5490982A (en) * 1995-02-01 1996-02-13 Elizabeth Arden Company, Division Of Conopco, Inc. Cosmetic composition
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
AU1068499A (en) * 1997-10-06 1999-04-27 Alza Corporation Injection-moldable composition and article of manufacture comprising same
JP2002512187A (ja) * 1998-04-17 2002-04-23 バーテック ファーマシューティカルズ，インコーポレイティド 爪真菌病の処置のための局所製剤
DK1031347T3 (da) 1999-01-27 2002-07-08 Idea Ag Transnasal transport/immunisering med meget tilpasselige bærere
ES2173678T3 (es) 1999-01-27 2002-10-16 Idea Ag Vacunacion no invasiva a traves de la piel.
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
WO2000059483A2 (en) * 1999-04-01 2000-10-12 Alza Corporation Transdermal drug delivery devices comprising a polyurethane drug reservoir
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
US20020004065A1 (en) 2000-01-20 2002-01-10 David Kanios Compositions and methods to effect the release profile in the transdermal administration of active agents
WO2001091757A1 (fr) * 2000-05-31 2001-12-06 Nichiban Co., Ltd. Preparation streroide du type a absorption percutanee pour usage externe
DE10027258C1 (de) 2000-05-31 2001-10-31 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit okklusiver wirkstoffhaltiger Schicht und nicht-okklusiver Rückschicht
DE10114382A1 (de) * 2001-03-23 2002-09-26 Beiersdorf Ag Feuchtigkeitsaufnehmende Matrix auf Silikonbasis insbesondere zur Wundversorgung und/oder pharmazeutisch/kosmetischen Hautbehandlung
US6544927B2 (en) * 2001-04-28 2003-04-08 University Of Florida Use of α2-adrenergic receptor agonists and adrenergic inhibitors in reducing defoliation
KR100517637B1 (ko) * 2001-12-21 2005-09-28 씨제이 주식회사 섬수 정제 엑스 및 인삼 정제 엑스를 함께 함유하면서다른 정유 생약 성분은 함유하지 않는 조루증의 예방 및치료용 조성물
CA2480889C (en) 2002-03-14 2011-11-15 Medrx Co., Ltd. External preparation for wounds
US20040029959A1 (en) * 2002-08-08 2004-02-12 John Devane Isosorbide mononitrate compositions and methods of their use
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
CA2584475A1 (en) * 2004-11-12 2006-05-18 Idea Ag Extended surface aggregates in the treatment of skin conditions
US8026266B2 (en) * 2005-11-08 2011-09-27 Arcion Therapeutics, Inc. Treatment of length dependent neuropathy
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
KR100835074B1 (ko) * 2006-09-27 2008-06-03 조선대학교산학협력단 멜록시캄 경피 흡수제 조성물 및 그의 제조 방법
EP2084124B9 (de) 2006-10-02 2015-07-01 Techfields Biochem Co. Ltd Positiv geladene wasserlösliche prodrugs von prostaglandinen und verwandten verbindungen mit sehr hohen hautpenetrationsraten
CN101541743A (zh) 2006-11-08 2009-09-23 于崇曦 多肽及相关化合物的透皮给药系统
ES2633020T3 (es) 2006-12-10 2017-09-18 Yu, Chongxi-Techfields Biochem Sistemas de administración transdérmica de antibióticos betalactámicos
JP5826459B2 (ja) 2007-01-15 2015-12-02 チョンシー ユー 非常に高い皮膚浸透率を有するレチノイド及びレチノイド様化合物の正に荷電した水溶性プロドラッグ
AU2007345952C1 (en) 2007-01-31 2017-06-08 Chongxi Yu Positively charged water-soluble prodrugs of 1H-imidazo[4, 5-c]quinolin-4-amines and related compounds with very high skin penetration rates
KR20180049144A (ko) 2007-06-04 2018-05-10 테크필즈 인크 매우 높은 피부 및 막 침투율을 가지는 비스테로이드성 소염제(ｎｓａｉａ) 약물전구체 및 이들의 새로운 의약적 용도
JP2012511027A (ja) * 2008-12-04 2012-05-17 チョンシー ユー 高透過性組成物およびその用途
CN102459313A (zh) 2009-05-08 2012-05-16 上海泰飞尔生化技术有限公司 多肽和多肽相关化合物的高穿透力前药组合物
US9969751B2 (en) 2009-06-10 2018-05-15 Techfields Pharma Co., Ltd. High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
KR102309973B1 (ko) 2012-01-18 2021-10-06 테크필즈 파마 코., 엘티디. 폐 병태의 치료를 위한 고침투 전구약물 조성물 및 그의 약제학적 조성물

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3262450A (en) * 1962-04-02 1966-07-26 Nathaniel M Elias Vaginal applicator
US3624224A (en) * 1969-12-22 1971-11-30 Schering Corp Novel first aid products
US3985892A (en) * 1971-04-15 1976-10-12 Jouveinal S.A. Pharmaceutical preparation for percutaneous treatment of local edemas employing acetazolamide
FR2133505B1 (de) * 1971-04-15 1974-08-23 Jouveinal Sa
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3972995A (en) * 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
SU806037A1 (ru) * 1978-04-06 1981-02-23 Всесоюзный Кардиологический Научныйцентр Amh Cccp Антиангинальное средство
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
JPS607966B2 (ja) * 1980-06-28 1985-02-28 日東電工株式会社 貼付剤
JPS57116011A (en) * 1981-01-08 1982-07-19 Nitto Electric Ind Co Ltd Pharmaceutical preparation
JPS6059207B2 (ja) * 1981-03-13 1985-12-24 日東電工株式会社 複合製剤の製法
JPS6059209B2 (ja) * 1981-08-27 1985-12-24 日東電工株式会社 複合製剤
JPS6059208B2 (ja) * 1981-08-27 1985-12-24 日東電工株式会社 複合製剤
GB2105990B (en) * 1981-08-27 1985-06-19 Nitto Electric Ind Co Adhesive skin patches
DE3205504C2 (de) * 1982-02-16 1983-12-01 Dolorgiet Gmbh & Co Kg, 5300 Bonn Äußerlich anwendbares, Ibuprofen enthaltendes Arzneimittel
US4695464A (en) * 1984-10-09 1987-09-22 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
US4699779A (en) * 1986-02-18 1987-10-13 Victor Palinczar Waterproof sunscreen compositions

Also Published As

Publication number Publication date
JPS59181207A (ja) 1984-10-15
CA1209476A (fr) 1986-08-12
FR2542998A1 (fr) 1984-09-28
EP0123585A3 (en) 1985-10-02
EP0123585B1 (de) 1988-08-31
US4746509A (en) 1988-05-24
FR2542998B1 (fr) 1986-01-31
EP0123585A2 (de) 1984-10-31
ATE36809T1 (de) 1988-09-15
JPH0430372B2 (de) 1992-05-21

Similar Documents

Publication Publication Date Title
DE3473732D1 (en) Transdermal drug form
DK288987A (da) Et afgivelsessystem til doseringsformerne forhalet afgivelse, samt dettes fremstilling
TW252919B (de)
GR3004531T3 (de)
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
AU4089189A (en) The use of asymmetric membranes in delivery devices
IE882960L (en) Osmotic dosage form for administering isradipine
DE68913461D1 (de) Wässrige Verteilung, Verbundpulver und Organosol vom Fluorid enthaltenden Polymerisat.
NL192822B (nl) In compartimenten verdeelde pleisters voor transdermale en dermale toediening.
ES510765A0 (es) Procedimiento y dispositivo para la entrega de concentrados viscosos con una viscosidad modificable, en cantidades dosificables con exactitud, de volumen variable.
SE7906119L (sv) Lekemedel-retardform med olosliga porosa diffusionsholjen
MX9606490A (es) Nanoparticulas estabilizadas y filtrables en condiciones esteriles.
DE69205931D1 (de) Copolymere Dispersion in aliphatischen Lösungsmitteln.
DE3782865D1 (de) Pfropfcopolymer mit einem stabilisationseffekt fuer dispersionen, dessen herstellungsverfahren und verfahren fuer eine emulsionspolymerisation mit diesem stabilisiermittel.
ES2060791T3 (es) Composiciones cationicas para aplicacion topica.
EP0134483A3 (de) Hautbehandlungsmittel
MY107070A (en) Improved pesticidal composition
DE3580925D1 (de) Faserfoermiger polymerlatex, faserfoermiges feinverteiltes polymerpulver und das feinverteilte pulver in nichtwaessrigem medium enthaltende dispersionen.
ATE60231T1 (de) Unloesliches arzneimittel das lokal im ohr verabreicht wird.
PL251852A1 (en) Biologically active killing agent in particular fungicide,aligicide,insecticide and/or acaricide
AU7817891A (en) Pharmaceuaticals with delayed release of active agent
EP0190860A3 (de) 6-Chloro-3-methyl-1H-2,3,4,5-tetrahydro-3-benzazepin-N-oxyd und dieses enthaltende Arzneimittel
NL8104180A (nl) Cytochinineachtig membraanactief preparaat voor de verhoging van de plantaardige produktiviteit, van het eiwitstikstofniveau en van de anionenopname.
Juma Social structure, educational disparities and elite schooling in Pakistan
ES2023624A4 (es) Procedimiento y dispositivo para la eliminacion de arsenico, estaño y antimonio de plomo de obra mediante oxigeno.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee